NCAPG2 and carcinoma: Such findings undoubtedly imply that NCAPG2 might play a key role in maintaining the homeostatic survival of carcinomas and could be a promising target for cancer therapy owing to its remarkable ability to control intermitotic chromatin condensation (9, 10, 13).